OCULOAURICULOVERTEBRAL DYSPLASIA

This adverse event was reported 72 times

These drugs are most commonly taken by patients reporting OCULOAURICULOVERTEBRAL DYSPLASIA:

# Drug Count
0 LAMOTIRIGINE 13
1 LAMOTRIGINE 13
2 LAMOTRIGINE CHEWABLE DISPERSIBLE 13
3 LAMOTRIGINE EXTENDED-RELEASE 13
4 NAPROXEN SODIUM 10
5 FLUOXETINE HYDROCHLORIDE 9
6 FOLIC ACID 6
7 NAPROXEN 6
8 FLUOXETINE 5
9 PAROXETINE HYDROCHLORIDE 5
See all common drugs associated with OCULOAURICULOVERTEBRAL DYSPLASIA

OCULOAURICULOVERTEBRAL DYSPLASIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE 1 0.0019
1 CLOMIPHENE CITRATE 1 0.0007
2 MENOTROPINS 1 0.0005
3 REMDESIVIR 5 0.0004
4 NAPROXEN SODIUM 220MG 4 0.0003
5 METHYLDOPA 1 0.0002
6 LAMOTIRIGINE 13 0.0002
7 LAMOTRIGINE CHEWABLE DISPERSIBLE 13 0.0002
8 TAMOXIFEN CITRATE 1 0.0002
9 TRETINOIN 1 0.0001
See all drugs enriched for association with OCULOAURICULOVERTEBRAL DYSPLASIA

OCULOAURICULOVERTEBRAL DYSPLASIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] 5 0.0004
1 Mood Stabilizer [EPC] 13 0.0001
2 Anti-epileptic Agent [EPC] 13 0.0001
3 Nitroimidazole Antimicrobial [EPC] 3 0.0000
4 Progesterone [EPC] 1 0.0000
5 Vitamin D [EPC] 6 0.0000
6 Vitamin B12 [EPC] 6 0.0000
7 Calcineurin Inhibitor Immunosuppressant [EPC] 2 0.0000
8 Vitamin C [EPC] 6 0.0000
9 Cardiac Glycoside [EPC] 1 0.0000
See all drug classes enriched for association with OCULOAURICULOVERTEBRAL DYSPLASIA